AI assistant
Tatva Chintan Pharma Chem Limited — Call Transcript 2022
Jan 15, 2022
59570_rns_2022-01-15_6671b7e5-8a02-4314-b576-0bb90de32673.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [521 x 81] intentionally omitted <==
Date: 15 January 2022 Ref No: TCPCL/SEC/2021-22/00054
| Date: 15 January 2022Ref No: TCPCL/SEC/2021-22/00054 | Date: 15 January 2022Ref No: TCPCL/SEC/2021-22/00054 |
|---|---|
| To, | |
| The General Manager,Corporate relationship department,BSE LimitedPhiroze Jeejeebhoy Towers,Dalal Street, Fort,Mumbai-400 001Scrip Code: 543321Through: BSE Corporate Compliance & Listing Centre | The Manager,Listing department,National Stock Exchange of India LimitedExchange Plaza, C-1, Block-G,Bandra-Kurla, Complex Bandra(E),Mumbai-400 051Scrip Symbol: TATVAThrough: NEAPS |
Sub: Intimation of Schedule of Earnings Call
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we would like to inform you that the Earnings Call post announcement of financial results of the Company for the quarter ended 31 December 2021, is scheduled on Tuesday, 18 January 2022 at 16:00 hours (IST).
The Call is hosted by DART (Dolat Analysis & Research Themes) and an invite in this regard is attached for your information and records.
Thanking you.
Yours faithfully.
Tatva Chintan Pharma Chem Limited
==> picture [69 x 31] intentionally omitted <==
==> picture [28 x 29] intentionally omitted <==
Apurva Dubey
Company Secretary And Compliance Officer
Membership No: A41130
As encl
Factory and Registered Office : Plot No. 502/17, G.I.D.C. Estate, Ankleshwar - 393 002, District:Bharuch, Gujarat, India.
SEZ Unit: Plot No. Z/103/F/1 and Plot No. Z/103/F/2, SEZ Area Part-2 , Dahej - 392 130, District: Bharuch, Gujarat, India.
DSIR Approved R & D Centre: Plot No. 353, G.I.D.C., Makarpura, Vadodara - 390 010, Gujarat, India. Telephone No. +91 75748 48533 / 34 Fax : +91 265 263 8533
E-mail: [email protected] Website : www.tatvachintan.com
==> picture [120 x 90] intentionally omitted <==
==> picture [167 x 60] intentionally omitted <==
You are cordially invited to the Earnings Call of
Tatva Chintan Pharma Chem Limited. to discuss the Q3FY22 Results
| Represented by: | |
|---|---|
| Mr. Chintan ShahMr. Ashok Bothra | Managing DirectorChief Financial Officer |
| Conference Dial-In Number | |
| Universal Dial In | +91 22 6280 1116+91 22 7115 8017 |
| International Toll Free | |
| Hong Kong: 800 964 448Singapore: 800 101 2045USA: 1 866 746 2133UK: 0 808 101 1573 |
Date: Tuesday, 18[th] January 2022 Time: 04:00 PM (I.S.T)
Click here for your Diamond Pass
RSVP:
Archit Joshi Tejas Sonawane Alpesh Lad Research Analyst Associate Associate (M) +91 98200 45344 (M) +91 98677 10940 (M) +91 94039 86676 [email protected] [email protected] [email protected]